WS
NARI

Wedbush Securities’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Wedbush Securities’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,319
Closed -$207K – 1307
2024
Q1 		$207K Sell
4,319
-230
-5% -$12.3K 0.01% 1084
2023
Q4 		$295K Sell
4,549
-450
-9% -$27.1K 0.01% 777
2023
Q3 		$327K Sell
4,999
-563
-10% -$35.4K 0.02% 687
2023
Q2 		$323K Sell
5,562
-700
-11% -$44.2K 0.02% 716
2023
Q1 		$387K Buy
6,262
+1,225
+24% +$73.5K 0.02% 630
2022
Q4 		$320K Sell
5,037
-590
-10% -$42.8K 0.02% 710
2022
Q3 		$409K Sell
5,627
-210
-4% -$15.6K 0.02% 589
2022
Q2 		$397K Sell
5,837
-385
-6% -$27.7K 0.02% 624
2022
Q1 		$564K Buy
6,222
+257
+4% +$21K 0.03% 532
2021
Q4 		$544K Sell
5,965
-100
-2% -$8.57K 0.02% 585
2021
Q3 		$492K Buy
6,065
+495
+9% +$41.6K 0.02% 624
2021
Q2 		$520K Buy
+5,570
New +$540K 0.02% 606

Other funds holding NARI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HCC Manager Chicago, Illinois $10.3M AUM 6.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wedbush Securities's NARI Position: Q2 2024 in Review

Wedbush Securities sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2024, closing a stake of 4,319 shares — an estimated $207K sold.

Wedbush Securities first reported a position in NARI in Q2 2021 and held it in 12 quarters. The position peaked at $564K in Q1 2022. 243 funds tracked by Wall St. Rank hold NARI as of Q2 2024.

  • Wedbush Securities reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Wedbush Securities sold 4,319 Inari Medical, Inc. Common Stock shares in Q2 2024, an estimated $207K.
  • Wedbush Securities first reported a position in Inari Medical, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Wedbush Securities's Inari Medical, Inc. Common Stock position peaked at $564K in Q1 2022.
  • 243 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2024.

Based on Wedbush Securities's 13F filing for Q2 2024, filed 7 Aug 2024.